$LRMR 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers The Board of Directors (the “Board”) of Larimar Therapeutics, Inc. (the “Company”) appointed John B. Harlow, Jr. as the Company’s President and Chief Operating Officer pursuant to the terms of an employment agreement with Mr. Harlow (the...
04 Aug 2026	8-K: Results of Operations and Financial Condition; Other Events
29 Jun 2026	8-K: Other Events
19 May 2026	8-K: Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Results of Operations and Financial Condition; Other Events
19 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Other Events
27 Feb 2026	8-K: Entry into a Material Definitive Agreement
24 Feb 2026	8-K: Other Events
22 Jan 2026	8-K: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year
12 Jan 2026	8-K: Results of Operations and Financial Condition; Other Events
17 Dec 2025	8-K: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year
10 Nov 2025	8-K: Other Events
05 Nov 2025	8-K: Results of Operations and Financial Condition
14 Oct 2025	8-K: Other Events
29 Sep 2025	8-K: Other Events
14 Aug 2025	8-K: Results of Operations and Financial Condition; Other Events
31 Jul 2025	8-K: Entry into a Material Definitive Agreement
29 Jul 2025	8-K: Results of Operations and Financial Condition
23 Jun 2025	8-K: Other Events

Comments